COMMUNIQUÉS West-GlobeNewswire

Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
14/03/2019
- New commercial strategy including optimized salesforce structure, new distribution network and focus on improving net margins expected to accelerate path to profitability – - Company to host conference call today at 8 [...]
Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
– Company is poised to advance multiple formulations of Triferic®, the first and only FDA-approved therapy indicated to replace iron and maintain hemoglobin levels in adult hemodialysis patients – WIXOM, Mich., March 14 [...]
Medtronic Board Appoints Andrea J. Goldsmith, Ph.D. as a New Director
14/03/2019
DUBLIN - March 14, 2019 - Medtronic plc (NYSE:MDT) today announced that its Board of Directors has appointed Andrea J. Goldsmith, Ph.D. to the Board as an independent director, effective March 11, 2019. Dr. Goldsmith is [...]
HEXO reports over $16.2 million in total gross revenue in the second quarter of fiscal 2019
14/03/2019
Key highlights of second quarter of 2019 fiscal year Gross revenue increased 1,269% as compared to the second quarter of fiscal 2018 and increased144% from the first quarter of fiscal 2019 Gross adult-use revenue in Q2 [...]
HEXO annonce des revenus bruts totaux de plus de 16,2 M$ au deuxième trimestre de l’exercice 2019
14/03/2019
Faits marquants du deuxième trimestre de l’exercice 2019 Les produits bruts ont augmenté de 1 269 % par rapport au deuxième trimestre de l’exercice 2018 et de 144 % par rapport au premier trimestre de l’exercice 2019. [...]
Loos, France, RLG Headquarter, March 14th 2019 : ISOLIFE - Radiopharma Logistics Group (RLG) ; AFNOR ISO 9001-2015 certification maintained for the “transport organization of radioactive and hazardous materials”.
14/03/2019
Following the March 2019 AFAQ audit, Isolife is pleased to announce that is AFAQ ISO 9001 V2015 was maintained, for the “transport organization of radioactive and hazardous materials”. Fabrice Nibart, Isolife President [...]
Loos, France, siège d'Isovital, 14 mars 2019 : ISOLIFE - Radiopharma Logistics Group (RLG) ; certification AFAQ 9001-2015 maintenue pour « l’organisation de transport de matières radioactives et dangereuses».
14/03/2019
Suite à l’audit de mars 2019, Isolife est heureux d’annoncer le maintien de sa certification AFAQ 9001-2015 pour « l’organisation de transport de matières radioactives et dangereuses » Fabrice Nibart, Président d’ [...]
Align Technology Announces Strategic Alliance With Digital Smile Design
14/03/2019
Bringing Dedicated Tools That Incorporate Digital Smile Design Into Align’s End-to-End Digital Workflow, Including iTero® Scanning Technology COLOGNE, Germany and SAN JOSE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- [...]
Novartis announces change in Sandoz leadership
14/03/2019
Richard Francis, CEO Sandoz, to step down on March 31, 2019 Francesco Balestrieri, Head Region Europe, Sandoz, appointed ad-interim CEO Sandoz Basel, March 14, 2019 - Novartis announced today that Richard Francis will [...]
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS
14/03/2019
Enrollment Announced During MS Awareness Week NEW YORK and CLEVELAND, March 14, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in developing innovative autologous cellular [...]
Extendicare Announces Exit from B.C. Market in 2020
14/03/2019
MARKHAM, Ontario, March 13, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it has received notice from Fraser Health and Vancouver Coastal Health, both [...]
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019
14/03/2019
RALEIGH, N.C., March 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation [...]
Protalix BioTherapeutics to Postpone the 2018 Financial Results and Corporate Update Conference Call
13/03/2019
CARMIEL, Israel, March 13, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
ADMA Biologics Reports Full Year 2018 Financial Results
13/03/2019
RAMSEY, N.J. and BOCA RATON, Fla., March 13, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Zafgen to Present at the 31st Annual ROTH Conference
13/03/2019
BOSTON, March 13, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18
13/03/2019
NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial [...]
Axovant Sciences Announces Public Offering of Common Shares
13/03/2019
NEW YORK and BASEL, Switzerland, March 13, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXGT) ("Axovant") today announced that it has commenced an underwritten public offering of its common shares. All of the [...]
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
13/03/2019
SOUTH SAN FRANCISCO, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that Gerald [...]
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
13/03/2019
SAN DIEGO, March 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Pages